News

FFG will grant 1.19 m EUR in the first year and an additional funding up to 70% of the total budget of 12.5 m EUR will be made

This is the fourth ‘Request for Proposals’ (RFP) issued through the multi-year collaboration between Fast Forward and Merck KGaA to drive the commercial development of MS therapies. Fast

Kalydeco was studied among people with CF ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator

The investigational trial is designed to assess the safety and efficacy of CD07805/47. The results demonstrated that CD07805/47 was effective in reducing facial redness. The trial also showed

According to the company, the submission would pave the way for an Investigational New Drug (IND) Application in the US. The manufacturers have produced research grade GAP-107B8 and

Under the terms of the collaborative agreement, VaxyGen and Georgia State University will work in the commercial development of the resident know-how and technology. VaxyGen provides custom contract

The patent, ‘Modified anticholinergic neurotoxins as modulators of the autoimmune reaction’ describes a composition of matter and method of its use to treat multiple sclerosis in humans. The

Under the terms of the partnership, Bend Research clients will have access to Hovione’s commercial-scale pharmaceutical manufacturing facilities and give Hovione clients access to Bend Research’s oral drug-delivery,

As per the contract, SAIC will provide product development services either directly or through management of subcontractors in areas including assay development, cGMP manufacture, feasibility assessments, process development,